ArticleJournal of dental sciences2025
Increased medications in the aged patients with burning mouth syndrome: A potentially overlooked risk factor.
Article in Journal of dental sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hidden pain: Diagnostic and management challenges of burning mouth syndrome.Journal of dental sciences · 2026Article
- Increased medications in patients with burning mouth syndrome should not Be overlooked, especially for older women.Journal of dental sciences · 2026Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose: Burning mouth syndrome (BMS) is a chronic oral mucosal burning and pain disorder, predominantly affecting the middle-aged and elderly women. This study aimed to explore the association between polypharmacy and BMS, with consideration of the patients' age and sex. Materials and methods: Medical data from 115 BMS patients and 115 age- and sex-matched control subjects were collected. Medications were categorized into four groups based on the number of medications taken. The chi-square test, Student's Results: A higher proportion of individuals with medications was observed in the BMS group than in the control group ( Conclusion: These findings suggest a potential association between multiple medications and the risk of having BMS and supported the need to consider polypharmacy as a contributing factor for the older BMS patient. However, future studies should be conducted to explore the exact dose-response trend and the influence of other associated factors on BMS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.